Tailored smoking treatment shows promise for vulnerable patients
NCT ID NCT04590404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a personalized approach to help people quit smoking by matching medication to their nicotine metabolism. 606 adults on Medicaid or Medicare who smoked daily took part. The goal was to see if tailoring treatment improves quit rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center ViTAL, Vanderbilt Center for Tobacco, Addiction, and Lifestyle General Internal Medicine and Public Health 2525 West End Ave, Suite 450
Nashville, Tennessee, 37203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app help smokers quit for good?
- Smoking ban may shield Non-Smokers' blood vessels
- Financial incentives and counseling aim to help homeless veterans quit smoking
- Heated tobacco devices tested as a tool to help smokers kick the habit
- Video games and medication join forces to help people with mental illness quit smoking
- Lawyers and pharmacists team up to help coal miners kick tobacco